This drug was first approved in 2017 by the brand name Ozempic for the treatment of diabetes
Some prescriptions, however, include several fills, meaning that this approach is likely to have excluded some patients who received their GLP-1 RA throughout the baseline period
While effective for many individuals, it can interact with other medications, potentially causing serious health effects
Insulin resistance is often linked to weight gain and difficulty losing weight, so improving this function can indirectly support weight loss
Phase 2 trials in obesity and type 2 diabetes reported the body-weight and blood-sugar results
GLP-1 is a natural hormone produced by your body after eating, to help regulate your blood sugar and lower your appetite